ABSTRACT
Indications for radiotherapy Testicular cancer is the most common malignancy in young men, affecting about 2000 a year in the UK. Ninety per cent of patients present with low stage I-IIB disease. Eighty per cent have clinical stage I disease confined to the testis with normalised tumour markers after orchidectomy. The cure rate for clinical stage I testis cancer is expected to be 100 per cent. To achieve this, patients should be managed by experienced health professionals, using consensus guidelines such as those from the European Germ Cell Cancer Consensus Group (EGCCCG, see below), which outline the current standards of care.
